P. Maria and D. , , 1996.

P. Ralph and G. , , 1996.

P. Duong-quang and T. , , 1997.

P. Marc and L. , Institute of Technology, 2005.

P. Yunfeng and Z. , , 2009.

P. David and A. , , 2011.

, Americain Psychiatric Association. DSM-III-R, Manuel diagnostique et statistique des troubles mentaux, 1987.

, Americain Psychiatric Association. DSM-5, Manuel diagnostique et statistique des toubles mentaux, 2015.

A. S. Bassett, S. W. Scherer, and L. M. Brzustowicz, Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease, Am J Psychiatry. août, vol.167, issue.8, pp.899-914, 2010.

S. Borges, C. Gayer-anderson, and V. Mondelli, A systematic review of the activity of the hypothalamic-pituitary-adrenal axis in first episode psychosis, Psychoneuroendocrinology. mai, vol.38, issue.5, pp.603-614, 2013.

M. Cannon, A. Caspi, T. E. Moffitt, H. Harrington, A. Taylor et al., Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry, vol.59, pp.449-56, 2002.

H. Cao, J. Duan, D. Lin, Y. Y. Shugart, V. Calhoun et al., Sparse representation based biomarker selection for schizophrenia with integrated analysis of fMRI and SNPs, Neuroimage, vol.102, issue.1, pp.220-228, 2014.

M. K. Chan, M. G. Gottschalk, F. Haenisch, J. Tomasik, T. Ruland et al., Applications of blood-based protein biomarker strategies in the study of psychiatric disorders, Prog Neurobiol. nov, vol.122, pp.45-72, 2014.

M. K. Chan, M. Krebs, D. Cox, P. C. Guest, R. H. Yolken et al., Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset, Transl Psychiatry. 14 juill, vol.5, p.601, 2015.

R. Chan, X. Di, G. M. Mcalonan, and Q. Gong, Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression, Schizophr Bull. janv, vol.37, issue.1, pp.177-88, 2011.

J. Chapman, The early symptoms of schizophrenia, Br J Psychiatry. mars, vol.112, issue.484, pp.225-51, 1966.

N. Charrier, K. Chevreul, and I. Durand-zaleski,

. Encephale and . Mai, , vol.39, pp.49-56, 2013.

B. Chaumette, O. Kebir, C. Mam-lam-fook, Y. Morvan, J. Bourgin et al., Salivary cortisol in early psychosis: New findings and meta-analysis, Psychoneuroendocrinology. janv, vol.63, pp.262-70, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01312810

C. Corcoran, D. Malaspina, and L. Hercher, Prodromal interventions for schizophrenia vulnerability: the risks of being « at risk, Schizophr Res. 1 mars, vol.73, issue.2-3, pp.173-84, 2005.

T. J. Craig, E. J. Bromet, S. Fennig, M. Tanenberg-karant, J. Lavelle et al., Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series?, Am J Psychiatry. janv, vol.157, issue.1, pp.60-66, 2000.

T. J. Crow, J. F. Macmillan, A. L. Johnson, and E. C. Johnstone, A randomised controlled trial of prophylactic neuroleptic treatment, Br J Psychiatry. févr, vol.148, pp.120-127, 1986.

W. W. Eaton, M. Badawi, and B. Melton, Prodromes and precursors: epidemiologic data for primary prevention of disorders with slow onset, Am J Psychiatry. juill, vol.152, issue.7, pp.967-72, 1995.

S. H. Fatemi and T. D. Folsom, The neurodevelopmental hypothesis of schizophrenia, revisited, Schizophr Bull. mai, vol.35, issue.3, pp.528-576, 2009.

J. I. Friedman, P. D. Harvey, E. Kemether, W. Byne, and K. L. Davis, Cognitive and functional changes with aging in schizophrenia, Biol Psychiatry, vol.46, issue.7, pp.921-929, 1999.

P. Fusar-poli, J. M. Stone, M. R. Broome, I. Valli, A. Mechelli et al., Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis, Arch Gen Psychiatry. sept, vol.68, issue.9, pp.881-90, 2011.

P. Fusar-poli, S. Borgwardt, A. Bechdolf, J. Addington, A. Riecher-rössler et al., The psychosis high-risk state: a comprehensive state-ofthe-art review, JAMA Psychiatry. janv, vol.70, issue.1, pp.107-127, 2013.

P. Fusar-poli, J. Perez, M. Broome, S. Borgwardt, A. Placentino et al., Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis, Neurosci Biobehav Rev, vol.31, issue.4, pp.465-84, 2007.

P. Fusar-poli, J. Radua, P. Mcguire, and S. Borgwardt, Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies, vol.38, pp.1297-307, 2012.

I. Gasman and J. Allilaire, Psychiatrie de l'enfant, de l'adolescent et de l'adulte. 2ème édition. Masson, 2009.

L. Girshkin, S. L. Matheson, A. M. Shepherd, and M. J. Green, Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis. Psychoneuroendocrinology, vol.49, pp.187-206, 2014.

D. Gourion, R. Gourevitch, J. Leprovost, H. Olié, J. Krebs et al.,

, Encephale. avr, vol.30, issue.2, pp.109-127, 2004.

D. Gourion, G. Viot, C. Goldberger, M. Cartier, M. C. Bourdel et al.,

, Encephale. avr, vol.27, issue.2, pp.143-150, 2001.

H. Häfner, K. Maurer, and W. Der-heiden, ABC Schizophrenia study: an overview of results since 1996, Soc Psychiatry Psychiatr Epidemiol. juill, vol.48, issue.7, pp.1021-1052, 2013.

R. W. Heinrichs and K. K. Zakzanis, Neurocognitive deficit in schizophrenia: a quantitative review of the evidence, Neuropsychology. juill, vol.12, issue.3, pp.426-471, 1998.

A. L. Hoff, M. Sakuma, K. Razi, G. Heydebrand, J. G. Csernansky et al., Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia, Am J Psychiatry, vol.157, issue.11, pp.1824-1832, 2000.

O. D. Howes, S. K. Bose, F. Turkheimer, I. Valli, A. Egerton et al., Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study, Am J Psychiatry. déc, vol.168, issue.12, pp.1311-1318, 2011.

E. Jääskeläinen, P. Juola, N. Hirvonen, J. J. Mcgrath, S. Saha et al., A systematic review and meta-analysis of recovery in schizophrenia, Schizophr Bull, vol.39, issue.6, pp.1296-306, 2013.

H. J. Jackson, P. D. Mcgorry, and P. Dudgeon, Prodromal symptoms of schizophrenia in first-episode psychosis: prevalence and specificity, Compr Psychiatry. août, vol.36, issue.4, pp.241-50, 1995.

M. Krebs, Signes précoces de schizophrénie: Des prodromes à la notion de prévention. Dunod, 2015.

M. Krebs, E. Magaud, D. Willard, C. Elkhazen, F. Chauchot et al., Évaluation des états mentaux à risque de transition psychotique : validation de la version française de la CAARMS, L'Encéphale. déc, vol.40, issue.6, pp.447-56, 2014.

M. Krebs and S. Mouchet, Neurological soft signs and schizophrenia: a review of current knowledge, Rev Neurol (Paris). déc, vol.163, issue.12, pp.1157-68, 2007.

V. Laprevote, U. Heitz, D. Patrizio, P. Studerus, E. Ligier et al., Pourquoi et comment soigner plus précocement les troubles psychotiques ? La Presse Médicale, 2016.

M. Marshall, S. Lewis, A. Lockwood, R. Drake, P. Jones et al., Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review, Arch Gen Psychiatry. sept, vol.62, issue.9, pp.975-83, 2005.

M. Marshall and J. Rathbone, Early intervention for psychosis, Cochrane Database Syst Rev. 15 juin, issue.6, p.4718, 2011.

O. Martin-santiago, J. Gomez-pilar, A. Lubeiro, M. Ayuso, J. Poza et al., Modulation of brain network parameters associated with subclinical psychotic symptoms, Progress in Neuro-Psychopharmacology and Biological Psychiatry. 3 avr, vol.66, pp.54-62, 2016.
DOI : 10.1016/j.pnpbp.2015.11.010

T. H. Mcglashan, Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? Biol Psychiatry, vol.46, pp.899-907, 1999.

A. Mechelli, A. Riecher-rössler, E. M. Meisenzahl, S. Tognin, S. J. Wood et al., Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study, Arch Gen Psychiatry. mai, vol.68, issue.5, pp.489-95, 2011.

L. T. Niemi, J. M. Suvisaari, A. Tuulio-henriksson, and J. K. Lönnqvist, Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies, Schizophr Res. 1 avr, vol.60, issue.2-3, pp.239-58, 2003.
DOI : 10.1016/s0920-9964(02)00234-7

C. Obacz, N. Jay, F. Ligier, and B. Kabuth, Clinique de l'enfance d'une population d'adultes schizophrènes. Étude rétrospective à propos de 50 cas. Neuropsychiatrie de l'Enfance et de l'Adolescence, vol.60, pp.526-559, 2012.

Y. Odagaki, Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics?, Curr Drug Saf. janv, vol.4, issue.1, pp.84-93, 2009.
DOI : 10.2174/157488609787354387

URL : http://www.benthamscience.com/cds/samples/cds4-1/0013CDS.pdf

M. J. Owen, M. C. O'donovan, A. Thapar, and N. Craddock, Neurodevelopmental hypothesis of schizophrenia, Br J Psychiatry. mars, vol.198, issue.3, pp.173-178, 2011.
DOI : 10.1192/bjp.bp.110.084384

URL : https://www.cambridge.org/core/services/aop-cambridge-core/content/view/193CA07A34E8188E7B324541EA601547/S000712500025441Xa.pdf/div-class-title-neurodevelopmental-hypothesis-of-schizophrenia-div.pdf

B. W. Palmer, R. K. Heaton, J. S. Paulsen, J. Kuck, D. Braff et al., Is it possible to be schizophrenic yet neuropsychologically normal?, Neuropsychology. juill, vol.11, issue.3, pp.437-483, 1997.
DOI : 10.1037/0894-4105.11.3.437

C. Pantelis, D. Velakoulis, P. D. Mcgorry, S. J. Wood, J. Suckling et al., Neuroanatomical abnormalities before and after onset of psychosis: a crosssectional and longitudinal MRI comparison, Lancet. 25 janv, vol.361, issue.9354, pp.281-289, 2003.
DOI : 10.1016/s0140-6736(03)12323-9

URL : http://midag.cs.unc.edu/pubs/papers/Lancet-Schizo.pdf

D. O. Perkins, H. Gu, K. Boteva, and J. A. Lieberman, Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis, Am J Psychiatry, vol.162, issue.10, pp.1785-804, 2005.

S. Raymond, M. Martin, C. Netillard, E. Mejat-alder, M. Woronoff-lemsi et al., Schizophrénie : évaluation du coût de la prise en charge, Journal d'économie médicale. 13 sept, vol.27, issue.7, pp.421-454, 2013.

F. Rivollier, L. Lotersztajn, B. Chaumette, M. Krebs, and O. Kebir,

. Encephale, , vol.40, pp.380-386, 2014.

M. Saoud, D. Amato, and T. , La schizophrénie de l'adulte, des causes aux traitements, 2006.

B. G. Schimmelmann, C. G. Huber, M. Lambert, S. Cotton, P. D. Mcgorry et al., Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort, J Psychiatr Res, vol.42, issue.12, pp.982-90, 2008.

, Biological insights from 108 schizophrenia-associated genetic loci, Schizophrenia Working Group of the Psychiatric Genomics Consortium, vol.511, pp.421-428, 2014.

S. J. Schmidt, F. Schultze-lutter, B. G. Schimmelmann, N. P. Maric, R. Salokangas et al., EPA guidance on the early intervention in clinical high risk states of psychoses, Eur Psychiatry. mars, vol.30, issue.3, pp.388-404, 2015.

J. Schulz, J. Sundin, S. Leask, and D. J. Done, Risk of adult schizophrenia and its relationship to childhood IQ in the 1958 British birth cohort, Schizophr Bull. janv, vol.40, issue.1, pp.143-51, 2014.

J. Shi, D. F. Levinson, J. Duan, A. R. Sanders, Y. Zheng et al., Common variants on chromosome 6p22.1 are associated with schizophrenia, Nature. 6 août, vol.460, issue.7256, pp.753-760, 2009.

S. M. Stahl, Psychopharmacologie essentielle, bases neuroscientifiques et applications pratiques. 4ème édition, 2015.

J. M. Stone, F. Day, H. Tsagaraki, I. Valli, M. A. Mclean et al., Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume, Biol Psychiatry. 15 sept, vol.66, issue.6, pp.533-542, 2009.

P. F. Sullivan, M. J. Daly, and M. O'donovan, Genetic architectures of psychiatric disorders: the emerging picture and its implications, Nat Rev Genet. 10 juill, vol.13, issue.8, pp.537-51, 2012.
DOI : 10.1038/nrg3240

URL : http://europepmc.org/articles/pmc4110909?pdf=render

F. Thibaut, Hypothèse neuro-développementale de la schizophrénie, L'Encéphale, vol.32, issue.5, pp.879-82, 2006.

J. Welham, M. Isohanni, P. Jones, and J. Mcgrath, The Antecedents of Schizophrenia: A Review of Birth Cohort Studies, Schizophr Bull. mai, vol.35, issue.3, pp.603-626, 2009.

S. J. Wood, A. R. Yung, P. D. Mcgorry, and C. Pantelis, Neuroimaging and treatment evidence for clinical staging in psychotic disorders: from the at-risk mental state to chronic schizophrenia, Biol Psychiatry, vol.70, issue.7, pp.619-644, 2011.

N. R. Wray, S. H. Lee, D. Mehta, A. Vinkhuyzen, F. Dudbridge et al., Research review: Polygenic methods and their application to psychiatric traits, J Child Psychol Psychiatry, vol.55, issue.10, pp.1068-87, 2014.
DOI : 10.1111/jcpp.12295

Z. Yin, J. Li, Y. Zhang, A. Ren, V. Meneen et al., Functional brain network analysis of schizophrenic patients with positive and negative syndrome based on mutual information of EEG time series, Biomedical Signal Processing and Control. janv, vol.31, pp.331-339, 2017.

A. R. Yung, B. Nelson, C. Stanford, M. B. Simmons, E. M. Cosgrave et al., Validation of « prodromal » criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up, Schizophr Res, vol.105, issue.1-3, pp.10-17, 2008.

, World Health Organization, Mental Health Atlas, vol.544, 2005.